BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 618595)

  • 1. Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man.
    Edvinsson L; Hardebo JE; Owman C
    Circ Res; 1978 Jan; 42(1):143-51. PubMed ID: 618595
    [No Abstract]   [Full Text] [Related]  

  • 2. Procaine-induced contraction in vein and its modification by drugs.
    Sanders HD
    Can J Physiol Pharmacol; 1969 Feb; 47(2):218-21. PubMed ID: 5783166
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of serotonin-receptors in intracranial and extracranial vessels.
    Edvinsson L; Hardebo JE
    Acta Physiol Scand; 1976 Aug; 97(4):523-5. PubMed ID: 970148
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-Hydroxytryptamine receptors. Contractile activity and mode of inhibition by methysergide in mammalian intracranial and extracranial vessels.
    Lamar JC; Edvinsson L
    Arch Int Pharmacodyn Ther; 1980 Feb; 243(2):245-54. PubMed ID: 7377898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin antagonism in isolated canine cerebral arteries.
    Toda N; Hayashi S; Fu WL; Nagasaka Y
    Jpn J Pharmacol; 1976 Feb; (1):57-63. PubMed ID: 1263357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasomotor response of cerebral blood vessels to dopamine and dopaminergic agonists.
    Edvinsson L; Hardebo JE; McCulloch J; Owman C
    Adv Neurol; 1978; 20():85-96. PubMed ID: 676925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopaminergic agonists and antagonists on isolated cerebral blood vessels.
    Edvinsson L; Hardebo JE; McCulloch J; Owman C
    Acta Physiol Scand; 1978 Nov; 104(3):349-59. PubMed ID: 716985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mode of action of ergometrine in the isolated dog coronary artery.
    Sakanashi M; Yonemura KI
    Eur J Pharmacol; 1980 Jun; 64(2-3):157-60. PubMed ID: 7398759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological in vitro analysis of amine-mediated vasomotor functions in the intracranial and extracranial vascular beds.
    Owman C; Edvinsson L; Hardebo JE
    Blood Vessels; 1978; 15(1-3):128-47. PubMed ID: 630128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of 5-hydroxytryptamine receptors through inhibition by methergoline in cat pial arteries in vitro.
    Edvinsson L; Hardebo JE
    Br J Pharmacol; 1978 Oct; 64(2):281-3. PubMed ID: 708997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic component in the vasoconstriction induced by 5-hydroxytryptamine in goat cerebral arteries.
    Marin J; Salaices M; Gómez B; Lluch S
    J Pharm Pharmacol; 1981 Nov; 33(11):715-9. PubMed ID: 6118410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the contractile effect of 5-hydroxytryptamine on the isolated posterior communicating artery of the cat.
    Marín J; Salaices M; Marco EJ; Gómez B; Lluch S
    J Pharm Pharmacol; 1979 Jul; 31(7):456-9. PubMed ID: 38315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of catecholamines on smooth muscle motility and phosphorylase activity.
    Diamond J; Brody TM
    J Pharmacol Exp Ther; 1966 May; 152(2):202-11. PubMed ID: 4380268
    [No Abstract]   [Full Text] [Related]  

  • 14. Some properties of prostaglandin E1 action on muscle.
    Khairallah PA; Page IH; Türker RK
    Arch Int Pharmacodyn Ther; 1967 Oct; 169(2):328-41. PubMed ID: 4294268
    [No Abstract]   [Full Text] [Related]  

  • 15. Similarities between the pharmacological actions of quipazine and serotonin.
    Hong E; Sancilio LF; Vargas R; Pardo EG
    Eur J Pharmacol; 1969; 6(3):274-80. PubMed ID: 5816391
    [No Abstract]   [Full Text] [Related]  

  • 16. Receptors involved in the 5-hydroxytryptamine-induced contraction of isolated cerebral arteries.
    Young AR; MacKenzie ET; Seylaz J; Verrecchia C
    Acta Physiol Scand Suppl; 1986; 552():54-7. PubMed ID: 3468750
    [No Abstract]   [Full Text] [Related]  

  • 17. The action of 5,6-dihydroxytryptamine on 5-hydroxytryptamine receptors.
    Carruba M
    Adv Biochem Psychopharmacol; 1974; 10():103-7. PubMed ID: 4846534
    [No Abstract]   [Full Text] [Related]  

  • 18. The 5-hydroxytryptamine-like actions of 5,6-dihydroxytryptamine.
    Barzaghi F; Baumgartner HR; Carruba M; Mantegazza P; Pletscher A
    Br J Pharmacol; 1973 Jun; 48(2):245-54. PubMed ID: 4733727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the receptor mediating contraction of human umbilical artery by 5-hydroxytryptamine.
    McGrath JC; MacLennan SJ; Stuart-Smith K
    Br J Pharmacol; 1985 Jan; 84(1):199-202. PubMed ID: 3978312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of serotonin upon the isolated iris sphincter of the cat.
    Koella WP; Rubin R; Schaeppi U
    J Pharmacol Exp Ther; 1967 Mar; 155(3):440-8. PubMed ID: 6022618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.